cagrilintide glp 1 Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit CagriSema vs Semaglutide: Dual Amylin/GLP-1

More importantly, unlike other GLP-1R monoagonists (22, 23, 26), I-M-150847-mediated incretin receptor activation is short-lived as it coincides with the spatial location of the activated receptor at the plasma membrane

Position of the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and Athletic Performance

Cell Mol Gastroenterol Hepatol

Many GLP-1s are already FDA approved and physicians can legally prescribe them off-label for any use

If malnutrition continues despite appropriate dosing, a consultation with a dietitian is suggested to evaluate and modify enzyme therapy and total dietary energy